CHOP researchers participated in clinical trial that led to approval of Harmony™ Transcatheter Pulmonary Valve (TPV), which allows for valve replacement without open-heart surgery.

Sometimes rare and super rare genetic conditions occur within the same child. That’s the case for Turner syndrome, which has an incidence rate of about 1 in 2,500 female births, and congenital hyperinsulinism, which happens about once in 50,000 births.

Last fall, Leela Morrow, PsyD, joined the team at the Congenital Hyperinsulinism Center at Children’s Hospital of Philadelphia, adding another service to the comprehensive program.

Our team offers a wide array of treatment options and resources to support families who turn to us for expert care when expecting a baby with congenital diaphragmatic hernia (CDH).

A physiologically based approach to umbilical cord clamping for infants with CDH may smooth the postnatal transition and prevent acidosis and hypoxemia.

It is well known that having a baby in the neonatal intensive care unit is a highly stressful experience for parents, and rates of parental anxiety and depression are routinely shown to be higher than for parents in the general population.

CHOP's specialized Pulmonary Hypoplasia Program provides ongoing developmental and medical assessments from infancy through adolescence, with the goal of looking beyond short-term surgical survival and providing long-term clinical care to improve quality of life.

Learn more about Children’s Hospital of Philadelphia's efforts to define the underlying genetic etiologies of CDH to better understand why CDH occurs and how it can be more effectively treated.

Early recognition, treatment and management of CDH-related pulmonary hypertension is critical. Our team takes an early and aggressive approach to treatment, and our protocols have been extremely successful.

 In honor of Social Work Month, CHOP is featuring our Community Health Workers.